Back to search

Article

A Potent Bispecific Nanobody Protects hACE2 Mice Against SARS-CoV-2 Infection via Intranasal Administration

2021-04-23

Abstract excerpt

The dramatically expanding COVID-19 needs multiple effective countermeasures. Neutralizing nanobodies (Nbs) are a potential therapeutic strategy for treating COVID-19. Here, we characterized several RBD-specific Nbs isolated from an Nb library derived from an alpaca immunized with SARS-CoV-2 spike glycoprotein (S); among them, three Nbs exhibited picomolar potency against SARS-CoV-2 live virus, pseudotyped viruse...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
78e2acb8-72d2-5b4e-955d-2e8f491b84d5
DOI
10.2139/ssrn.3832975
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Potent Bispecific Nanobody Protects hACE2 Mice Against SARS-CoV-2 Infection via Intranasal AdministrationDOI 10.2139/ssrn.3832975
Select a neighboring publication to make it the new centre.